Medicon Hellas Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Dimotsantos Spyridon
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 3.6yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 3.6yrs |
Recent management updates
Recent updates
Medicon Hellas (ATH:MEDIC) Has Announced That It Will Be Increasing Its Dividend To €0.06
Jul 11
Medicon Hellas (ATH:MEDIC) Is Reinvesting At Lower Rates Of Return
Aug 04There Are Reasons To Feel Uneasy About Medicon Hellas' (ATH:MEDIC) Returns On Capital
Feb 18Medicon Hellas (ATH:MEDIC) May Have Issues Allocating Its Capital
Jun 10Estimating The Intrinsic Value Of Medicon Hellas S.A. (ATH:MEDIC)
Apr 30Investors Could Be Concerned With Medicon Hellas' (ATH:MEDIC) Returns On Capital
Sep 30Medicon Hellas (ATH:MEDIC) Could Easily Take On More Debt
Jun 07Based On Its ROE, Is Medicon Hellas S.A. (ATH:MEDIC) A High Quality Stock?
Feb 25The Returns At Medicon Hellas (ATH:MEDIC) Provide Us With Signs Of What's To Come
Nov 23
CEO
Dimotsantos Spyridon (77 yo)
3.6yrs
Tenure
Mr. Dimotsantos S. Spyridon is CEO & Chairman of the Board of Medicon Hellas S.A. from June 30, 2021. He serves as a Chief Executive Officer of Medicon Hellas S.A.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman of the Board | 3.6yrs | no data | no data | |
| Deputy CEO & Executive Director | 10.8yrs | no data | no data | |
| Independent Non Executive Director | 3.6yrs | no data | no data | |
| Independent Non-Executive Director | 3.6yrs | no data | no data | |
| Independent Non-Executive Director | 3.6yrs | no data | no data | |
| Independent Non-Executive Director | 3.6yrs | no data | no data |
3.6yrs
Average Tenure
59.5yo
Average Age
Experienced Board: MEDIC's board of directors are considered experienced (3.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 05:21 |
| End of Day Share Price | 2025/01/02 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Medicon Hellas S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|